IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway
Xiaorong Zhou,1,* Yuxu Feng,2,* Siwen Liu,1 Chenchen Li,1 Yue Teng,1 Xiaoyou Li,1 Jianwei Lu1 1Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009 Jiangsu Province, People&rsq...
Main Authors: | Zhou X, Feng Y, Liu S, Li C, Teng Y, Li X, Lu J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-03-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/il-33-promotes-the-growth-of-non-small-cell-lung-cancer-cells-through--peer-reviewed-article-CMAR |
Similar Items
-
IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway [Corrigendum]
by: Zhou X, et al.
Published: (2021-03-01) -
MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
by: Danxia Cao, et al.
Published: (2020-09-01) -
Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease
by: Zhang M, et al.
Published: (2021-01-01) -
Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]
by: Zhang M, et al.
Published: (2021-02-01) -
Knockdown of lncRNA PCAT1 Enhances Radiosensitivity of Cervical Cancer by Regulating miR-128/GOLM1 Axis
by: Ge X, et al.
Published: (2020-10-01)